GlassScriptPhysician profile
Waleed M Khalil
NPI 1700879723
$3,832.70
in general payments reported to CMS, 2019-2025
27 companies · $660 in 2025
The $660 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $215 · 2022: $1,148 · 2023: $696 · 2024: $1,114 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,469.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,462.14 | 2021-2025 | Xifaxan, Plenvu, Trulance |
| Genzyme Corporation | $476.71 | 2022-2025 | |
| Abbvie INC. | $459.70 | 2021-2025 | |
| Ardelyx, INC. | $167.36 | 2022-2025 | Ibsrela |
| Qol Medical, LLC | $139.02 | 2024 | Sucraid |
| Madrigal Pharmaceuticals | $117.79 | 2024-2025 | Resmetirom, Rezdiffra |
| Ironwood Pharmaceuticals, INC | $108.38 | 2022-2024 | Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $102.94 | 2021-2024 | Entyvio |
| Pfizer INC. | $79.29 | 2025 | |
| Nestle Healthcare Nutrition INC. | $73.45 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $72.60 | 2022-2025 | |
| Boston Scientific Corporation | $68.01 | 2024 | Cre Pro, Resolution 360 Clip |
| Janssen Biotech, INC. | $63.64 | 2022-2025 | Tremfya |
| Braintree Laboratories, INC. | $56.97 | 2021-2022 | |
| Gilead Sciences, INC. | $50.05 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $47.68 | 2024 | |
| Daiichi Sankyo INC. | $46.03 | 2022 | |
| Ferring Pharmaceuticals INC. | $44.57 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $32.40 | 2022-2024 | Airsupra |
| Csl Behring | $27.39 | 2021 | |
| Olympus America INC. | $23.92 | 2025 | Single Use Repositionable Clip |
| Glaxosmithkline, LLC. | $22.10 | 2024 | Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $19.87 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $19.50 | 2022 | |
| Celgene Corporation | $18.63 | 2024 | Zeposia |
| Novo Nordisk INC | $17.95 | 2025 | Wegovy |
| Axonics, INC. | $14.61 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waleed Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.